Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Patient Preference and Adherence|November 23, 2013
Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophreniaGabriel Kaplan, Julio Casoy, Jacqueline Zummo
Early Intervention in Psychiatry|September 26, 2015
Clinical benefits and impact of early use of long-acting injectable antipsychotics for schizophreniaGeorgia L Stevens, Gail Dawson, Jacqueline Zummo
BMC Medical Informatics and Decision Making|December 6, 2019
Proof-of-concept study: Homomorphically encrypted data can support real-time learning in personalized cancer medicineSilvia Paddock, Hamed Abedtash, Jacqueline Zummo, et al.
Pathogens and Global Health|January 17, 2017
Toxoplasmic encephalitis relapse rates with pyrimethamine-based therapy: systematic review and meta-analysisMark P Connolly, Elizabeth Goodwin, Carina Schey, et al.
Future Oncology (London, England)|July 27, 2017
Dynamic value assessments in oncology supported by the PACE Continuous Innovation IndicatorsSilvia Paddock, Clifford Goodman, Scott Shortenhaus, et al.
Sleep Medicine|April 3, 2012
A WASO sub-group analysis of a 6-month study of eszopiclone 3 mgAndrew D Krystal, Holly Huang, Jacqueline Zummo, et al.
Journal of Managed Care & Specialty Pharmacy|August 27, 2015
Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital DischargeSteven C Marcus, Jacqueline Zummo, Amy R Pettit, et al.
Journal of Addiction Medicine|March 31, 2017
Open-label Study of Injectable Extended-release Naltrexone (XR-NTX) in Healthcare Professionals With Opioid DependencePaul H Earley, Jacqueline Zummo, Asli Memisoglu, et al.
Journal of Clinical Psychopharmacology|June 16, 2015
Concurrent Oral Antipsychotic Drug Use Among Schizophrenia Patients Initiated on Long-Acting Injectable Antipsychotics Post-Hospital DischargeJalpa A Doshi, Amy R Pettit, Jeffrey J Stoddard, et al.
Current Medical Research and Opinion|November 29, 2017
Efficacy and safety of aripiprazole lauroxil once-monthly versus aripiprazole once-monthly long-acting injectable formulations in patients with acute symptoms of schizophrenia: an indirect comparison of two double-blind placebo-controlled studiesChris Cameron, Jacqueline Zummo, Dharmik Desai, et al.
Pageof 2